Josh McCreary - 08 Mar 2023 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
Senior VP & General Counsel
Signature
/s/ Josh A. McCreary
Issuer symbol
NHC
Transactions as of
08 Mar 2023
Transactions value $
$0
Form type
4
Filing time
09 Mar 2023, 17:17:18 UTC
Previous filing
04 Jan 2023
Next filing
22 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHC Shares of Common Stock Award $0 +728 +28.47% $0.00 3.29K 08 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock Award $0 +12K $0.00 12K 08 Mar 2023 Common Stock 12K $53.94 Direct F2, F3
holding NHC Option to Purchase Common Stock 11.2K 08 Mar 2023 Common Stock 11.2K $63.96 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2024, the next 33 1/3% vesting on 1/1/2025, and the final 33 1/3% vesting on 1/1/2026.
F2 These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F3 This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on March 8, 2024; one-third (1/3) will vest on March 8, 2025; and the final one-third (1/3) will vest on March 8, 2026.